SEARCH

SEARCH BY CITATION

References

  • Allen S. J., Wilcock G. K. and Dawbarn D. (1999) Profound and selective loss of catalytic TrkB immunoreactivity in Alzheimer’s disease. Biochem. Biophys. Res. Commun. 264, 648651.
  • Arevalo J. C. and Wu S. H. (2006) Neurotrophin signaling: many exciting surprises! Cell Mol. Life Sci. 63, 15231537.
  • Biffo S., Offenhauser N., Carter B. D. and Barde Y. A. (1995) Selective binding and internalisation by truncated receptors restrict the availability of BDNF during development. Development 121, 24612470.
  • Blalock E. M., Geddes J. W., Chen K. C., Porter N. M., Markesbery W. R. and Landfield P. W. (2004) Incipient Alzheimer’s disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc. Natl Acad. Sci. USA 101, 21732178.
  • Cartegni L., Wang J., Zhu Z., Zhang M. Q. and Krainer A. R. (2003) ESEfinder: a web resource to identify exonic splicing enhancers. Nucleic Acids Res. 31, 35683571.
  • Connor B., Young D., Yan Q., Faull R. L., Synek B. and Dragunow M. (1997) Brain-derived neurotrophic factor is reduced in Alzheimer’s disease. Brain Res. Mol. Brain Res. 49, 7181.
  • Ding S., Shi J., Qian W., Iqbal K., Grundke-Iqbal I., Gong C. X. and Liu F. (2012) Regulation of alternative splicing of tau exon 10 by 9G8 and Dyrk1A. Neurobiol. Aging. 33, 13891399.
  • Dreyfuss G., Kim V. N. and Kataoka N. (2002) Messenger-RNA-binding proteins and the messages they carry. Nat. Rev. Mol. Cell Biol. 3, 195205.
  • Eide F. F., Vining E. R., Eide B. L., Zang K., Wang X. Y. and Reichardt L. F. (1996) Naturally occurring truncated trkB receptors have dominant inhibitory effects on brain-derived neurotrophic factor signaling. J. Neurosci. 16, 31233129.
  • Faustino N. A. and Cooper T. A. (2003) Pre-mRNA splicing and human disease. Genes Dev. 17, 419437.
  • Ferrer I., Marin C., Rey M. J., Ribalta T., Goutan E., Blanco R., Tolosa E. and Marti E. (1999) BDNF and full-length and truncated TrkB expression in Alzheimer disease. Implications in therapeutic strategies. J. Neuropathol. Exp. Neurol. 58, 729739.
  • Fryer R. H., Kaplan D. R. and Kromer L. F. (1997) Truncated trkB receptors on nonneuronal cells inhibit BDNF-induced neurite outgrowth in vitro. Exp. Neurol. 148, 616627.
  • Gao L., Wang J., Wang Y. and Andreadis A. (2007) SR protein 9G8 modulates splicing of tau exon 10 via its proximal downstream intron, a clustering region for frontotemporal dementia mutations. Mol. Cell. Neurosci. 34, 4858.
  • Graveley B. R. (2000) Sorting out the complexity of SR protein functions. RNA 6, 11971211.
  • Gregory G. C., Macdonald V., Schofield P. R., Kril J. J. and Halliday G. M. (2006) Differences in regional brain atrophy in genetic forms of Alzheimer’s disease. Neurobiol. Aging 27, 387393.
  • Hanamura A., Caceres J. F., Mayeda A., Franza Jr B. R. and Krainer A. R. (1998) Regulated tissue-specific expression of antagonistic pre-mRNA splicing factors. RNA 4, 430444.
  • Heinrichs V. and Baker B. S. (1995) The Drosophila SR protein RBP1 contributes to the regulation of doublesex alternative splicing by recognizing RBP1 RNA target sequences. EMBO J. 14, 39874000.
  • Jiang Z., Cote J., Kwon J. M., Goate A. M. and Wu J. Y. (2000) Aberrant splicing of tau pre-mRNA caused by intronic mutations associated with the inherited dementia frontotemporal dementia with parkinsonism linked to chromosome 17. Mol. Cell. Biol. 20, 40364048.
  • Jumaa H. and Nielsen P. J. (1997) The splicing factor SRp20 modifies splicing of its own mRNA and ASF/SF2 antagonizes this regulation. EMBO J. 16, 50775085.
  • Kagedal K., Kim W. S., Appelqvist H., Chan S., Cheng D., Agholme L., Barnham K., McCann H., Halliday G. and Garner B. (2010) Increased expression of the lysosomal cholesterol transporter NPC1 in Alzheimer’s disease. Biochim. Biophys. Acta 1801, 831838.
  • Kalbfuss B., Mabon S. A. and Misteli T. (2001) Correction of alternative splicing of tau in frontotemporal dementia and parkinsonism linked to chromosome 17. J. Biol. Chem. 276, 4298642993.
  • Kamma H., Portman D. S. and Dreyfuss G. (1995) Cell type-specific expression of hnRNP proteins. Exp. Cell Res. 221, 187196.
  • Kim W. S., Bhatia S., Elliott D. A., Agholme L., Kagedal K., McCann H., Halliday G. M., Barnham K. J. and Garner B. (2010) Increased ATP-binding cassette transporter A1 expression in Alzheimer’s disease hippocampal neurons. J. Alzheimers Dis. 21, 193205.
  • Klein R., Conway D., Parada L. F. and Barbacid M. (1990) The trkB tyrosine protein kinase gene codes for a second neurogenic receptor that lacks the catalytic kinase domain. Cell 61, 647656.
  • Livak K. J. and Schmittgen T. D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402408.
  • Luberg K., Wong J., Weickert C. S. and Timmusk T. (2010) Human TrkB gene: novel alternative transcripts, protein isoforms and expression pattern in the prefrontal cerebral cortex during postnatal development. J. Neurochem. 113, 952964.
  • Neubauer G., King A., Rappsilber J., Calvio C., Watson M., Ajuh P., Sleeman J., Lamond A. and Mann M. (1998) Mass spectrometry and EST-database searching allows characterization of the multi-protein spliceosome complex. Nat. Genet. 20, 4650.
  • NIA (1997) Consensus recommendations for the postmortem diagnosis of Alzheimer’s disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer’s Disease. Neurobiol. Aging 18, S12.
  • Ninkina N., Adu J., Fischer A., Pinon L. G., Buchman V. L. and Davies A. M. (1996) Expression and function of TrkB variants in developing sensory neurons. EMBO J. 15, 63856393.
  • Ohira K. and Hayashi M. (2003) Expression of TrkB subtypes in the adult monkey cerebellar cortex. J. Chem. Neuroanat. 25, 175183.
  • Ohira K., Shimizu K., Yamashita A. and Hayashi M. (2005a) Differential expression of the truncated TrkB receptor, T1, in the primary motor and prefrontal cortices of the adult macaque monkey. Neurosci. Lett. 385, 105109.
  • Ohira K., Kumanogoh H., Sahara Y., Homma K. J., Hirai H., Nakamura S. and Hayashi M. (2005b) A truncated tropomyosin-related kinase B receptor, T1, regulates glial cell morphology via Rho GDP dissociation inhibitor 1. J. Neurosci. 25, 13431353.
  • Phillips H. S., Hains J. M., Armanini M., Laramee G. R., Johnson S. A. and Winslow J. W. (1991) BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer’s disease. Neuron 7, 695702.
  • Schonrock N., Ke Y. D., Humphreys D., Staufenbiel M., Ittner L. M., Preiss T. and Gotz J. (2010) Neuronal microRNA deregulation in response to Alzheimer’s disease amyloid-beta. PLoS One 5, e11070.
  • Snapyan M., Lemasson M., Brill M. S. et al. (2009) Vasculature guides migrating neuronal precursors in the adult mammalian forebrain via brain-derived neurotrophic factor signaling. J. Neurosci. 29, 41724188.
  • Stoilov P., Castren E. and Stamm S. (2002) Analysis of the human TrkB gene genomic organization reveals novel TrkB isoforms, unusual gene length, and splicing mechanism. Biochem. Biophys. Res. Commun. 290, 10541065.
  • Tazi J., Bakkour N. and Stamm S. (2009) Alternative splicing and disease. Biochim. Biophys. Acta 1792, 1426.
  • Wang Y., Wang J., Gao L., Stamm S. and Andreadis A. (2011) An SRp75/hnRNPG complex interacting with hnRNPE2 regulates the 5′ splice site of tau exon 10, whose misregulation causes frontotemporal dementia. Gene 485, 130138.
  • Wong J. and Garner B. (2012) Evidence that truncated TrkB isoform, TrkB-Shc can regulate phosphorylated TrkB protein levels. Biochem. Biophys. Res. Commun. 420, 331335.
  • Wong J., Quinn C. M., Gelissen I. C. and Brown A. J. (2008) Endogenous 24(S),25-epoxycholesterol fine-tunes acute control of cellular cholesterol homeostasis. J. Biol. Chem. 283, 700707.
  • Wong J., Rothmond D. A., Webster M. J. and Weickert C. S. (2011) Increases in two truncated TrkB isoforms in the prefrontal cortex of people with schizophrenia. Schizophr. Bull. Epub. doi: 10.1093/schbul/sbr070.
  • Wong J., Higgins M. J., Halliday G. and Garner B. (2012) Amyloid beta selectively modulates neuronal TrkB alternative transcript expression with implications for Alzheimer’s disease. Neuroscience 210, 363374.
  • Zheng Z. M. (2004) Regulation of alternative RNA splicing by exon definition and exon sequences in viral and mammalian gene expression. J. Biomed. Sci. 11, 278294.